|
1
|
Ren S, Zhang H, Mu Y, Sun M and Liu P:
Pharmacological effects of Astragaloside IV: a literature review. J
Tradit Chin Med. 33:413–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Hu G, Li S, et al: Pro-angiogenic
activity of astragaloside IV in HUVECs in vitro and zebrafish in
vivo. Mol Med Rep. 5:805–811. 2012.PubMed/NCBI
|
|
3
|
Zhang L, Liu Q, Lu L, Zhao X, Gao X and
Wang Y: Astragaloside IV stimulates angiogenesis and increases
hypoxia-inducible factor-1α accumulation via phosphatidylinositol
3-kinase/Akt pathway. J Pharmacol Exp Ther. 338:485–491.
2011.PubMed/NCBI
|
|
4
|
Wang SG, Xu Y, Chen JD, Yang CH and Chen
XH: Astragaloside IV stimulates angiogenesis and increases nitric
oxide accumulation via JAK2/STAT3 and ERK1/2 pathway. Molecules.
18:12809–12819. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choe N, Kwon JS, Kim JR, et al: The
microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle
cell proliferation and neointimal hyperplasia. Atherosclerosis.
229:348–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong S, Xiong W, Yuan J, Li J, Liu J and
Xu X: MiRNA-146a regulates the maturation and differentiation of
vascular smooth muscle cells by targeting NF-kappaB expression. Mol
Med Rep. 8:407–412. 2013.PubMed/NCBI
|
|
7
|
Lacolley P, Regnault V, Nicoletti A, Li Z
and Michel JB: The vascular smooth muscle cell in arterial
pathology: a cell that can take on multiple roles. Cardiovasc Res.
95:194–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang HM, Kim BK, Kim JY, et al: PPARγ
modulates vascular smooth muscle cell phenotype via a protein
kinase G-dependent pathway and reduces neointimal hyperplasia after
vascular injury. Exp Mol Med. 45:e652013.
|
|
9
|
Chen J, Xu L and Huang C: DHEA inhibits
vascular remodeling following arterial injury: a possible role in
suppression of inflammation and oxidative stress derived from
vascular smooth muscle cells. Mol Cell Biochem. 388:75–84. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pi Y, Zhang LL, Li BH, et al: Inhibition
of reactive oxygen species generation attenuates TLR4-mediated
proinflammatory and proliferative phenotype of vascular smooth
muscle cells. Lab Invest. 93:880–887. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yoo SH, Lim Y, Kim SJ, et al: Sulforaphane
inhibits PDGF-induced proliferation of rat aortic vascular smooth
muscle cell by up-regulation of p53 leading to G1/S cell cycle
arrest. Vascul Pharmacol. 59:44–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Donovan J, Abraham D and Norman J:
Platelet-derived growth factor signaling in mesenchymal cells.
Front Biosci (Landmark Ed). 18:106–119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang XP, Pei ZH and Ren J: Making up or
breaking up: the tortuous role of platelet-derived growth factor in
vascular ageing. Clin Exp Pharmacol Physiol. 36:739–747. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martin-Garrido A, Williams HC, Lee M, et
al: Transforming growth factor β inhibits platelet derived growth
factor-induced vascular smooth muscle cell proliferation via
Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One.
8:e796572013.
|
|
15
|
Park ES, Kang SI, Yoo KD, et al:
Camptothecin inhibits platelet-derived growth factor-BB-induced
proliferation of rat aortic vascular smooth muscle cells through
inhibition of PI3K/Akt signaling pathway. Exp Cell Res.
319:982–991. 2013. View Article : Google Scholar
|
|
16
|
Li FL, Li X, Wang YF, et al: Astragaloside
IV downregulates β-catenin in rat keratinocytes to counter
LiCl-induced inhibition of proliferation and migration. Evid Based
Complement Alternat Med. 2012:9561072012.
|
|
17
|
Branchetti E, Poggio P, Sainger R, et al:
Oxidative stress modulates vascular smooth muscle cell phenotype
via CTGF in thoracic aortic aneurysm. Cardiovasc Res. 100:316–324.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van der Veer EP, de Bruin RG, Kraaijeveld
AO, et al: Quaking, an RNA-binding protein, is a critical regulator
of vascular smooth muscle cell phenotype. Circ Res. 113:1065–1075.
2013.PubMed/NCBI
|
|
19
|
Gan J, Li P, Wang Z, et al: Rosuvastatin
suppresses platelet-derived growth factor-BB-induced vascular
smooth muscle cell proliferation and migration via the MAPK
signaling pathway. Exp Ther Med. 6:899–903. 2013.PubMed/NCBI
|
|
20
|
Salabei JK, Cummins TD, Singh M, Jones SP,
Bhatnagar A and Hill BG: PDGF-mediated autophagy regulates vascular
smooth muscle cell phenotype and resistance to oxidative stress.
Biochem J. 451:375–388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao Q, Zhang F, Grassia G, et al: Matrix
metalloproteinase-8 promotes vascular smooth muscle cell
proliferation and neointima formation. Arterioscler Thromb Vasc
Biol. 34:90–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karki R, Kim SB and Kim DW: Magnolol
inhibits migration of vascular smooth muscle cells via cytoskeletal
remodeling pathway to attenuate neointima formation. Exp Cell Res.
319:3238–3250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo J, Li L, Wu YJ, et al: Inhibitory
effects of Brazilin on the vascular smooth muscle cell
proliferation and migration induced by PDGF-BB. Am J Chin Med.
41:1283–1296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Risinger GM Jr, Updike DL, Bullen EC,
Tomasek JJ and Howard EW: TGF-beta suppresses the upregulation of
MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J
Physiol Cell Physiol. 298:C191–C201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karakiulakis G, Papakonstantinou E,
Aletras AJ, Tamm M and Roth M: Cell type-specific effect of hypoxia
and platelet-derived growth factor-BB on extracellular matrix
turnover and its consequences for lung remodeling. J Biol Chem.
282:908–915. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han SG, Newsome B and Hennig B: Titanium
dioxide nanoparticles increase inflammatory responses in vascular
endothelial cells. Toxicology. 306:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kanaji N, Nelson A, Wang X, et al:
Differential roles of JNK, ERK1/2, and p38 mitogen-activated
protein kinases on endothelial cell tissue repair functions in
response to tumor necrosis factor-α. J Vasc Res. 50:145–156.
2013.PubMed/NCBI
|
|
28
|
Jiang F, Jiang R, Zhu X, Zhang X and Zhan
Z: Genipin inhibits TNF-α-induced vascular smooth muscle cell
proliferation and migration via induction of HO-1. PLoS One.
8:e748262013.
|
|
29
|
Cheng C, Haasdijk RA, Tempel D, et al:
PDGF-induced migration of vascular smooth muscle cells is inhibited
by heme oxygenase-1 via VEGFR2 upregulation and subsequent assembly
of inactive VEGFR2/PDGFRβ heterodimers. Arterioscler Thromb Vasc
Biol. 32:1289–1298. 2012.PubMed/NCBI
|
|
30
|
Hu Y, Cheng P, Ma JC, Xue YX and Liu YH:
Platelet-derived growth factor BB mediates the glioma-induced
migration of bone marrow-derived mesenchymal stem cells by
promoting the expression of vascular cell adhesion molecule-1
through the PI3K, P38 MAPK and NF-κB pathways. Oncol Rep.
30:2755–2764. 2013.PubMed/NCBI
|
